Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    TED12414
Show Display Options
Rank Status Study
1 Active, not recruiting Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Condition: Neoplasm Malignant
Interventions: Drug: SAR245408;   Drug: SAR245409

Study has passed its completion date and status has not been verified in more than two years.